Cancer Center Seminar Series


photo of seminar

About the Seminar Series

Presented by Masonic Cancer Center, University of Minnesota this interdisciplinary seminar series provides a venue for basic-science and clinical faculty to hear about cutting-edge work in all areas of cancer. The series features invited speakers and MCC faculty with expertise in selected topics related to cancer. Speakers in our series represent the research programs of the MCC: Cell Signaling, Genetic Mechanisms, Tumor Microenvironment, Immunology, Transplant Biology & Therapy, Carcinogenesis and Chemoprevention, and SPECS-Screening, Prevention, Etiology and Cancer Survivorship.

Tuesdays, 9-10 a.m., Seminar Room, First Floor, Cancer and Cardiovascular Research Building (simulcast in 450 MCRB, Hormel Institute room 155, and Duluth, 112-SMed )

Seminar presentations can be recorded to view on the Web site. Presenters must give their permission in advance to have a seminar recorded.

For more information: 625-5129,

Upcoming Seminars

Masonic Cancer Center Seminar

February 28, 2017

Reducing Cancer Disparities in Indian Country: Pearls for investigators interested in working within the American Indian/Alaska Native Community
Amanda Bruegl, M.D., Oregon Health & Science University



Tracking progesterone receptor (PR) and estrogen receptor (ER) cross talk in breast cancer models

March 7, 2017

Carol Lange, PhD
Department of Medicine
University of Minnesota

Androgen receptor-dependent and -independent mechanisms driving prostate cancer progression: Opportunities for therapeutic targeting from multiple angles

March 14, 2017

Marja Nevalainen, MD, PhD
Department of Pharmacology & Toxicology
Medical College of Wisconsin
Associate Director of Education
Medical College of Wisconsin Cancer Center

Identification of cancer associated fibroblasts in circulating blood as an early detection method for metastatic breast cancer

March 21, 2017

Dorraya El-Ashry, PhD
Associate Professor of Medicine
Sylvester Comprehensive Cancer Center
University of Miami Health System

The 9-1-1-ATR-Chk1 signaling pathway and how it promotes tumor survival

March 28, 2017

Lenny Karnitz, Ph.D.
Professor of Pharmacology
Mayo Clinic Cancer Center
Rochester, MN

Endophilin-dynamin complex assembly - tumor suppression through coordinated membrane remodeling

April 11, 2017

Anna Sundborger, PhD                                         
Assistant Professor and Section Leader                            
Cryo-EM and Molecular Cell Biology                            
The Hormel Institute, University of Minnesota                                                     

Translational therapy with NK cells: Is there a commercial path?

April 18, 2017

Jeffrey Miller, MD
Department of Medicine
Deputy Director
Masonic Cancer Center
University of Minnesota

Anisotropic focal adhesion dynamics mediate contact guidance directed cell invasion

April 25, 2017

Paolo Provenzano, PhD
Assistant Professor

Department of Biomedical Engineering
University of Minnesota

On the road to precision medicine in gynecologic oncology

May 2, 2017

Boris Winterhoff, MD
Assistant Professor
Department of Obstetrics, Gynecology & Women's Health
University of Minnesota

Masonic Cancer Center Seminar

May 9, 2017

Cynthia Reinhart-King, Ph.D.
Associate Professor
Biomedical Engineering
Cornell University

Immunotherapy for metastatic melanoma 2017

May 16, 2017

Svetomir N. Markovic, M.D., Ph.D.
Professor of Medicine & Oncology
Mayo Clinic